These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16556152)

  • 1. Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy.
    Manzoor K; Ahmed E; Akhtar F; Kazi JI; Naqvi SA; Rizvi SA
    Clin Transplant; 2006; 20(1):43-7. PubMed ID: 16556152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
    Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
    Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of mycophenolate mofetil in patients with a transplanted kidney and cyclosporin nephrotoxicity].
    Hrvacević R; Ignjatović Lj; Vavić N; Dimitrijević J; Drasković-Pavlović B; Dujić A; Elaković D; Kronja G; Marić M
    Vojnosanit Pregl; 2001; 58(2):157-60. PubMed ID: 11475669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.
    Young BA; Marsh CL; Alpers CE; Davis CL
    Am J Kidney Dis; 1996 Oct; 28(4):561-71. PubMed ID: 8840947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
    Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW
    Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
    Zent R; Katz A; Quaggin S; Cattran D; Wade J; Cardella C; Zaltzman J; Fenton S; Cole E
    Clin Nephrol; 1997 Mar; 47(3):181-6. PubMed ID: 9105765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.
    Fortin MC; Raymond MA; Madore F; Fugère JA; Pâquet M; St-Louis G; Hébert MJ
    Am J Transplant; 2004 Jun; 4(6):946-52. PubMed ID: 15147429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
    Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
    J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine and tacrolimus-associated thrombotic microangiopathy.
    Pham PT; Peng A; Wilkinson AH; Gritsch HA; Lassman C; Pham PC; Danovitch GM
    Am J Kidney Dis; 2000 Oct; 36(4):844-50. PubMed ID: 11007689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy.
    Lecornu-Heuze L; Ducloux D; Rebibou JM; Martin L; Billerey C; Chalopin JM
    Nephrol Dial Transplant; 1998 Dec; 13(12):3212-3. PubMed ID: 9870494
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine.
    Pelletier RP; Akin B; Ferguson RM
    Clin Transplant; 2006; 20(1):10-8. PubMed ID: 16556147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature.
    Trimarchi HM; Truong LD; Brennan S; Gonzalez JM; Suki WN
    Transplantation; 1999 Feb; 67(4):539-44. PubMed ID: 10071024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.